Soluble adhesion molecules in pre-clinical Type 1 diabetes:: a prospective study (vol 46, pg 492, 2003)

被引：0
|
作者：
Toivonen, AM
Kulmala, P
Savola, K
Åkerblom, HK
Knip, M
机构：
[1] Univ Helsinki, Hosp Children & Adolescents, Helsinki 00029, Finland
[2] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland
[3] Tampere Univ Hosp, Dept Paediat, Tampere, Finland
[4] Univ Oulu, Dept Paediat, Oulu, Finland
来源：
DIABETOLOGIA | 2004年 / 47卷 / 01期
关键词：
D O I：
10.1007/s00125-003-1279-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [41] RETRACTION: Utilising Pre-clinical Models to Refine Immune Modulation in Pancreatic Cancer (Retraction of Vol 231, Pg S 1, 2013)
    Hagemann, Thorsten
    JOURNAL OF PATHOLOGY, 2016, 239 (03): : 384 - 384
  • [42] A PROSPECTIVE-STUDY IN TYPE-1 DIABETES - THE PRE-DIABETIC PERIOD AND THE RISK TO SIBLINGS
    GORSUCH, AN
    LISTER, J
    SPENCER, KM
    CUDWORTH, AG
    QUARTERLY JOURNAL OF MEDICINE, 1981, 50 (200): : 495 - 496
  • [43] Improved glycaemia in type 1 diabetes results in decreased levels of soluble adhesion molecules with no change in serum adiponectin or most acute phase proteins
    Heliovaara, M. K.
    Teppo, A. -M.
    Karonen, S. -L.
    Tuominen, J. A.
    Ebeling, P.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (06) : 295 - 300
  • [44] Soluble adhesion molecules, thrombomodulin and risk of developing Type 2 diabetes mellitus.: Preliminary results from the MONICA/KORA Augsburg study
    Thorand, B
    Baumert, J
    Schneider, A
    Löwell, H
    Kolb, H
    Koenig, W
    DIABETOLOGIA, 2004, 47 : A148 - A148
  • [45] Gene therapy for type 1 diabetes by engineering skeletal muscle to express insulin and glucokinase (GK): Pre-clinical studies in diabetic dogs
    Mann, Christopher J.
    Callejas, David
    Montane, Joel
    Ayuso, Edu
    Anguela, Xavier M.
    Moya, Marta
    Leon, Xavier
    Garcia, Felix
    Andaluz, Anna
    Bosch, Fatima
    DIABETES, 2008, 57 : A125 - A126
  • [46] The analysis of in vitro transforming growth factor β1 (TGF-β1) production by peripheral blood in overt and pre-clinical type 1 diabetes mellitus.
    Kretowski, A
    Kowalska, I
    Szelachowska, M
    Kinalska, I
    DIABETOLOGIA, 2000, 43 : A107 - A107
  • [47] The analysis of in vitro transforming growth factor-β1 (TGF-β1) production by peripheral blood in overt and pre-clinical type 1 diabetes mellitus
    Kretowski, A
    Maciej, K
    Ida, K
    IMMUNOLOGY LETTERS, 2000, 71 (02) : 85 - 89
  • [48] Novel force feedback technology improves suturing in robotic-assisted surgery: a pre-clinical study (vol 39, pg 1217, 2024)
    Servais, Elliot L.
    Rashidi, Laila
    Porwal, Priyanshi
    Garibaldi, Mark
    Hung, Andrew J.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2025, 39 (04): : 2750 - 2750
  • [49] Cell adhesion molecules, plasminogen activator inhibitor type 1, and metabolic syndrome in patients with psoriasis (vol 20, pg 39, 2019)
    Teixeira, Guilherme Gomes
    Mari, Naiara Lourenco
    de Paula, Jaqueline Costa Castardo
    de Alcantara, Camila Cataldi
    Flauzino, Tamires
    Lozovoy, Marcell Alysson Batisti
    Martin, Ligia Marcia Mario
    Reiche, Edna Maria Vissoci
    Maes, Michael
    Dichi, Isaias
    Simao, Andrea Name Colado
    CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 20 (01) : 49 - 49
  • [50] Evaluation of the benefits of a regional pre-pregnancy care program in women with type 1 and type 2 diabetes: a prospective study
    Mustafa, E.
    Kirwan, B.
    Khalil, S.
    Carmody, L.
    Gallacher, T.
    Mitchell, Y.
    Todd, M.
    Durkan, M.
    Dunne, F.
    DIABETOLOGIA, 2011, 54 : S403 - S404
12345